Managing vesicant extravasations.

Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

Anthracycline extravasation is an uncommon but very serious complication. Very few data are available in the literature concerning the consequences and the management of extravasation of liposomal doxorubicin. This report describes the cases of two patients with liposomal doxorubicin extravasation who developed irritant reaction without vesicant or necrotic lesions. It is concordant with other ...

[Rapid increase in incidence of melanoma in situ in Girona (Spain), 1994-2005. Effectiveness of public education campaigns about early diagnosis].

una complicación grave del tratamiento oncológico. Actas Dermosifiliogr. 2006;97:169-76. 2. Shulmeister L. Managing vesicant extravasations. Oncologist. 2008;13:284-8. 3. Wengstrom Y, Marguliesc A. European Oncology Nursing Society Extravasation Guidelines. Eur J Oncol Nurs. 2008;12:357-61. 4. Larson DL. What is the appropriate management of tissue extravasation by antitumor agents? Plast Recon...

Prevent extravasation injury with the use of antidotes.

A lthough vesicant extravasations are rare events, they have the potential to cause permanent damage to patient tissue. Developing or updating institutional policies on how to manage extravasations can be difficult because organizational guidelines and recommendations are published only periodically. In her article in the August 2009 issue of the Clinical Journal of Oncology Nursing, Lisa Schul...

Vesicant chemotherapy extravasation antidotes and treatments.

Oncology nurses and pharmacists often are given the responsibility of developing or updating institutional policies to manage vesicant chemotherapy extravasations. Antidote and treatment recommendations of vesicant chemotherapy manufacturers, antidotes and treatments approved by the U.S. Food and Drug Administration (FDA), and guidelines and recommendations made by professional oncology organiz...

Managing extravasations.